Renishaw Share Discussion Threads

[apad] 01/8/2019 08:35

Comment made on VLG board.

"Nothing very much to add. One bright comment about additive and I couldn't understand the impact of hedging.
Pension contributions have more than doubled."

Pretty much agree with red, but I think this is more than in the share price so expect it to continue bouncing along at current low levels, waiting for Godo.
Bigger falls if it was more liquid perhaps (cf XPP).
Apad

[redartbmud] 01/8/2019 08:26

broadwood

I expect the analysts to come out with some very negative comments in their updates. The problems are glaringly obvious:
New independent Chair and new FD. are urgently required.

[broadwood] 01/8/2019 08:23

Nevertheless Red we're still here.

I seem to remember a sharp fall a few months ago following a Broker downgrade so maybe Armageddon has been postponed judging by the very early share price action.

[redartbmud] 01/8/2019 07:34

Share price down 15 - 20% at the open.
Nothing positive in the commentary.
Healthcare is insignificant in the piece.

Ouch.

[fuji99] 01/8/2019 07:15

Disappointing results as they are below their last reduced projections.
Indirectly this is their 3rd revenues and profit warning.
Revenues expected to be at 580M - 600M against 574M (below lower end).
Profit at 109.9M against previously reduced 111M - 126M; again below lower end.
This means a sharp slowdown.
IMO, may struggle for the rest of the year.

[fuji99] 25/7/2019 11:29

Interesting news - - -
---------------

------------

------

[shaker44] 14/6/2019 05:59

Just read this tipped in IC tp of the week.
I see its well off last year's highs, and IC quote pe of 24, after two revenue warnings. Great rice and future prospects but looks interesting rather than compelling surely? Just feels a bit early in the Trump-China spat, and brexit uncertainty to jump in now.

Be interested in views from lths and others?

[pugugly] 18/5/2019 18:55

Peel Hunt comment -


Stroppy analyst as management will not really give him any attention as they concentrate on the business - ABSOLOUTELY CORRECT THING FOR THEM TO DO.
Over 90% of the city scribblers (imo) have very little real front line business experience and in many cases lack detailed insight into the companies on which they comment and the competition in their marketplaces - (not saying this is the case here but you only have to look at the recent Telegraph Article "When analysts say b uy it is time to sell"

The only thing he has got correct is that there is a very strong balance sheet - (imo) they also have market leading products and plough a lot into research - So they should succeed -

Mr market seems to agree with me as significant bounce back BUT a 3rd warning might make me change my mind - Declaration - Long term holder.

[philanderer] 14/5/2019 23:22

MARKET REPORT: Engineering firm Renishaw slides 6% after issuing a second profit warning in just two months

[pugugly] 14/5/2019 09:00

Nocton - Main reaaon (imo) is very illiquid and strongly held - Hence any significant volume - either way - has a major impact on the price .

[nocton] 14/5/2019 08:27

Last time this happened, in April, it rose £10 within a month! It is a very volatile share for some reason.

[pugugly] 14/5/2019 08:09

Results out - Top list faller down some £5 - Profits down but cash up - No debt - p/e very high - Starting to look as though may be ex growth.

[sspurt] 13/5/2019 11:22

Investor day tomorrow. Always interesting to see their products and well attended but don't expect management to say anything which throws any light on their financials.

[tsmith2] 19/10/2018 19:51

thanks. not sure the risk v benefit is attractive enough

[tsmith2] 19/10/2018 16:02

what does it say. Can you copy and paste on here pls

[zho] 19/10/2018 11:51

Covered at - not behind paywall

[shieldbug] 19/10/2018 10:12

To clarify, the recent pull back was sector wide - the drop following the trading statement - something else.

[shieldbug] 19/10/2018 09:48

Comparing Renishaw's share price to Robot ETFs suggests this is a sector wide effect. Sentiment based on trade tensions and poor economic outlook?

Would be interesting to know what caused the reduced profit but would guess cost of investment for future growth.

[pugugly] 18/10/2018 07:25

Trading statement out

Curate's egg - Revenue up 8% Profit down 9% - Net cash balance increased to £115.3M from £103.8 in June -
NO forward forcast - Anualised profit run rate decreased by £11 million -
Does not seem to be enough to justify the recent pull back unless now considered ex growth-

[helm1] 26/7/2018 13:35

Stonking results. Agree with pug's comments.

Every six months there seems to be a round of analyst write-ups saying the stock is over-valued, the price dips, the results come out and fully justify the high rating. I reckon the current share price is reflecting the wider market unease, rather than RSW's immediate prospects.

Is a PE in the range 30-33 excessive? I don't think so.

[redartbmud] 26/7/2018 08:42

Sorry. I looked a previous guidance.
Updated was
revenue to be in the range of £585m to £610m
adjusted profit before tax to be in the range of £135m to £150m

Happy with results.

[redartbmud] 26/7/2018 07:46

Smashed guidance of Revenue £520 - £535 and Profits £99m - £108m.

[pugugly] 26/7/2018 07:37

Results out - Again fantastic
Repeat 903 above
"City analists seem have have got a facefull of "merde" - Management have as usual deliverd excellent results - For the moment one to still hold long term."

Record revenue of £611.5m, with growth at constant exchange rates of 18%

• Revenue growth in all metrology product lines, with strong growth in measurement and automation, co-ordinate measuring machine, machine tool and additive manufacturing product lines

• Revenue growth in all healthcare product lines, with strong growth in our neurological product line

• Record adjusted profit before tax of £145.1m, with growth of 33%

• Healthcare business achieves profit for the first time, with adjusted profit before tax of £0.3m (2017: £7.2m loss)

• Capital expenditure of £34.9m, providing for future growth

• Headcount increase of 332, including 122 graduates and apprentices

• Strong balance sheet, with cash of £103.8m, compared with £51.9m last year

• Dividend increased by 15% to 60.0p
Cannot ask for more - OK p/e High but RSW continues to deliver. year on year +++++